How Will The Immunodiagnostics Market Expand At A CAGR Of 7.8% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
#How Will The Immunodiagnostics Market Valuation Change Between Now And 2029?#_x000D_
In recent years, the size of the immunodiagnostics market has experienced significant growth. It is projected to increase from $22.88 billion in 2024 to $24.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The historic growth of this market is linked to factors such as a rise in infectious and autoimmune diseases, the diagnosis and monitoring of cancer, the global spread of infectious diseases, public health efforts, and screening programs._x000D_
_x000D_
In the coming years, robust growth is anticipated in the size of the immunodiagnostics market, reaching a projection of $32.89 billion by 2029. This represents a compound annual growth rate (CAGR) of 7.8%. This growth, in the predicted period, is due to a number of factors. These include readiness and reactions to pandemics, tailored medicines and biomarker discovery, the expansion of healthcare infrastructure in new markets, coordination with laboratory information systems, and the increasing prevalence of chronic diseases. Expected trends within this forecast period encompass multiplexing technologies, point-of-care testing (POCT), novel findings in biomarkers and personalized medicine, the growing prominence of digital immunodiagnostics, and a shift towards liquid biopsy._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp_x000D_
_x000D_
#What Growth-Enabling Forces Are Impacting The Immunodiagnostics Market?#_x000D_
The rise in infectious diseases is projected to stimulate the immunodiagnostics market’s expansion. Infectious diseases are illnesses that are transmitted between individuals, caused by pathogens such as viruses, bacteria, fungi, or parasites. An immunodiagnostic test is utilized to detect a virus in a blood sample. For example, the Centers for Disease Control and Prevention, a government agency in the United States, reported in March 2024 that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, a surge of 1,295 cases. Therefore, the escalating prevalence of infectious diseases is predicted to enhance the growth of the immunodiagnostics market._x000D_
_x000D_
#What Are The Main Segment Classifications In The Immunodiagnostics Market?#_x000D_
The immunodiagnosticsmarket covered in this report is segmented –_x000D_
_x000D_
1) By Product: Reagents And Consumables, Instruments, Software And Services_x000D_
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies_x000D_
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications_x000D_
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates_x000D_
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers_x000D_
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services_x000D_
_x000D_
#How Are Industry Trends Steering The Expansion Of The Immunodiagnostics Market?#_x000D_
Leading firms in the immunodiagnostics market are concentrating their efforts on the creation of innovative solutions, such as the S. pneumoniae antigen immunodiagnostic test, to aid in identifying pneumococcal pneumonia infections. The S. pneumoniae Antigen Immunodiagnostic Test is used to check for Streptococcus pneumoniae antigens present in body fluids which assists in diagnosing pneumococcal diseases. An example of this occurred in September 2024, when DiaSorin S.p.A., a biotech company from Italy, introduced the LIAISON S. pneumoniae antigen immunodiagnostic test. This specific diagnostic examination, crafted for the qualitative detection of Streptococcus pneumoniae antigens in adult urine samples suspected of having pneumococcal pneumonia, provides a high-volume solution enabling healthcare professions to swiftly identify and differentiate pneumococcal pneumonia from other respiratory infections. Compatible with LIAISON CLIA analyzers, the test delivers results within 35 minutes, encouraging immediate, targeted antimicrobial treatment. It also possesses the capability to recognize 91 serotypes, which bolsters clinical decision-making and advocates effective antibiotic stewardship, marking a noteworthy advancement in the immunodiagnostics sector for community-acquired pneumonia._x000D_
_x000D_
#Which Firms Are Driving Innovation Within The Immunodiagnostics Market?#_x000D_
Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation_x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report_x000D_
_x000D_
#What Are The Emerging Regional Trends Driving The Immunodiagnostics Market?#_x000D_
North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp_x000D_
_x000D_
Browse Through More Reports Similar to the Global Immunodiagnostics Market 2025, By The Business Research Company_x000D_
_x000D_
Orphan Drug Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report_x000D_
_x000D_
Drug Delivery Devices Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report_x000D_
_x000D_
Autoimmune Disease Diagnosis Global Market Report 2025_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
